Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1 results about "Differential centrifugation" patented technology

Differential centrifugation (also differential velocity centrifugation) is a common procedure in biochemistry and cell biology used to separate organelles and other sub-cellular particles on the basis of sedimentation rate. Although often applied in biological analysis, differential centrifugation is a general technique also suitable for crude purification of non-living suspended particles (e.g. nanoparticles, colloidal particles, viruses). In a typical case where differential centrifugation is used to analyze cell-biological phenomena (e.g. organelle distribution), a tissue sample is first lysed to break the cell membranes and release the organelles and cytosol. The lysate is then subjected to repeated centrifugations, where particles that sediment sufficiently quickly at a given centrifugation force for a given time form a compact "pellet" at the bottom of the centrifugation tube. After each centrifugation, the supernatant (non-pelleted solution) is removed from the tube and re-centrifuged at an increased centrifugal force and/or time. Differential centrifugation is suitable for crude separations on the basis of sedimintation rate, but more fine grained purifications may be done on the basis of density through equilibrium density-gradient centrifugation.

Preparation method of human adipose mesenchymal stem cell exosome for treating myocardial infarction

PendingCN111944749AExosome effect is stableDamage reliefCell dissociation methodsSkeletal/connective tissue cellsCardiac functioningCytokine
The invention provides a preparation method of human adipose mesenchymal stem cell exosome for treating myocardial infarction, and relates to the technical field of biology. The preparation method ofthe human mesenchymal stem cell exosome for treating myocardial infarction provided by the invention comprises the following steps: culturing human adipose mesenchymal stem cells, and collecting a cell culture solution; and carrying out differential centrifugation on the cell culture solution, collecting the supernatant, carrying out ultracentrifugation on the supernatant to obtain target microspheres, and then filtering, purifying and sterilizing the target microspheres to obtain the human adipose mesenchymal stem cell exosome for treating myocardial infarction. According to the present invention, the advantage is that the human adipose mesenchymal stem cell exosome is prepared by culturing human adipose mesenchymal stem cells, and the human adipose mesenchymal stem cell exosome containsvarious RNAs and cytokines, so that infarcted myocardial cells are effectively repaired, the cardiac function is enhanced, compensatory myocardial load is reduced, and heart failure is relieved; and atreatment medicine or a treatment strategy is provided for myocardial infarction.
Owner:FUJIAN MEDICAL UNIV UNION HOSPITAL

Popular searches

Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products